Publication date: December 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 4 Author(s): Aastha Dhakal, Emily C. Zabor, Naveen Rehman, Bridget Adcock, Muaz Alsabbagh Alchirazi, Moath Albliwi, Ali Mushtaq, Hadil Zureigat, Monica Lee, Ahmed Nabil Mohamed Hassan, Heya Batah, Preeyal Patel, Meera Patel, Sara Haddad, Yang Wang, Michael Menefee, Khaled Aref Hassan, Marc A. Shapiro, James Stevenson, Alex A. Adjei
The changing landscape of stage IV lung squamous cell carcinoma: Long-term trends with immune checkpoint inhibitors and contemporary regimens. // International Journal of Lung Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S3117504X26000707?dgcid=rss_sd_all
The changing landscape of stage IV lung squamous cell carcinoma: Long-term trends with immune checkpoint inhibitors and contemporary regimens. International Journal of Lung Cancer. https://www.sciencedirect.com/science/article/pii/S3117504X26000707?dgcid=rss_sd_all
“The changing landscape of stage IV lung squamous cell carcinoma: Long-term trends with immune checkpoint inhibitors and contemporary regimens.” International Journal of Lung Cancer.
@article{article49799,
title = {The changing landscape of stage IV lung squamous cell carcinoma: Long-term trends with immune checkpoint inhibitors and contemporary regimens},
journal = {International Journal of Lung Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S3117504X26000707?dgcid=rss_sd_all}
}